RecruitingPhase 4NCT04219280

Evaluating Treatment of ADHD in Children with Down Syndrome

Studying Down syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Anna Esbensen, PhD
Children's Hospital Medical Center, Cincinnati
Intervention
Quillivant XR(drug)
Enrollment
100 enrolled
Eligibility
6-17 years · All sexes
Timeline
2020 – 2025

Study locations (4)

Collaborators

University of California, Davis · University of Pittsburgh Medical Center · Boston Children's Hospital, Boston, MA, USA

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04219280 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials